Biosimilars LatAm – Colombia 2023

The forum was created to serve as a platform for communication and collaboration between INVIMA, the national regulatory agency, and pharmaceutical manufacturers in the region. 

The forum aims to address pressing industry concerns, provide feedback, and identify potential next steps for the industry. The presence of international experts will also provide an opportunity to share best practices in communication and building trust between regulatory agencies and the companies they regulate, with a specific focus on the communication between the reference agency ANVISA and its regulated companies.

The program is designed to enhance the understanding of the local capacity for research and development of biosimilars, as well as to explore the potential for public-private partnerships between government entities and pharmaceutical companies to produce these treatments. 

The primary focus is on efforts by the National Government and private industries to identify and establish mutually beneficial alliances for technology transfer and the production of biosimilars, vaccines, and other medical technologies within Colombia.

This trend towards expansion, development, and investment in the biosimilars market holds great promise for patients as it can lead to greater access to therapeutic options and help to address disparities in healthcare access in the region.

Similar successful examples can be seen in neighboring countries like Brazil and Mexico, where biosimilars have been implemented to facilitate the production of Covid vaccines through Partnerships for Productive Development (PPD). The forum aims to replicate these successes within the region of Colombia.